Trials / Unknown
UnknownNCT00502398
Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Patients with hemolytic disorders (e.g. sickle cell anemia or thalassemia) are known to develop pulmonary hypertension. Hemolysis is where red blood cells are destroyed and their contents released into the circulation. It is thought that these red-cell contents cause constriction and thrombosis of the blood vessels in the lungs. Conversely, it is possible that patients with pulmonary hypertension have hemolysis. In this study we will be drawing blood from a range of patients and normal controls for a panel of blood tests related to hemolysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood test |
Timeline
- Start date
- 2007-09-01
- First posted
- 2007-07-17
- Last updated
- 2007-10-16
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00502398. Inclusion in this directory is not an endorsement.